Markets:

Overview

News

Currencies

International

Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

96.69 +1.49 (+1.57%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

71 72 Next >

Why BioNTech Stock Got Trounced on Tuesday ↗

May 06, 2025

Via The Motley Fool

BioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology Expansion ↗

May 05, 2025

BioNTech's Q1 revenue hit $192 million, beating estimates; company confirms 2025 outlook and names new CFO ahead of oncology-focused expansion.

Via Benzinga

BioNTech Announces First Quarter 2025 Financial Results and Corporate Update

May 05, 2025

From BioNTech SE

Via GlobeNewswire

BioNTech Announces Appointment of Ramón Zapata to Management Board as Chief Financial Officer

May 05, 2025

From BioNTech SE

Via GlobeNewswire

Earnings Scheduled For May 5, 2025 ↗

May 05, 2025

Via Benzinga

4 Analysts Have This To Say About BioNTech ↗

March 11, 2025

Via Benzinga

Want Safe Dividend Income in 2025 and Beyond? Invest in the Following 3 Ultra-High-Yield Stocks. ↗

May 01, 2025

There's no need to track down complicated and obscure businesses. Some of the market's best income-producing stocks are hiding in plain sight.

Via The Motley Fool

Topics Bonds World Trade

Trump-Era FDA Appointees Request New Trials For Novavax COVID Vaccine, Reportedly Delaying Approval Timeline ↗

April 29, 2025

The President Donald Trump administration's request for Novavax Inc. to conduct new clinical trials for its COVID-19 vaccine has created uncertainty across the vaccine industry, potentially affecting...

Via Benzinga

Topics Government

Why Is Summit Therapeutics Stock Trading Higher On Monday? ↗

April 28, 2025

Summit Therapeutics highlights China approval of Akeso's ivonescimab for NSCLC, with enrollment ongoing for Phase 3 HARMONi-7 trial.

Via Benzinga

Why Biotech Stars Summit Therapeutics and BioNTech Plunged, Even as This Chinese Rival Surged Today ↗

April 25, 2025

Via The Motley Fool

BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation Immuno-Oncology Priority Programs at AACR 2025

April 24, 2025

From BioNTech SE

Via GlobeNewswire

Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps ↗

April 23, 2025

Novavax's COVID-19 vaccine showed fewer side effects than Pfizer's in a Utah study as FDA seeks more data before full approval decision.

Via Benzinga

BioNTech Surges On Summit's Coattails. But Can They Take On Merck? ↗

April 23, 2025

BioNTech is on the rise after Summit Therapeutics unveiled promising results for its PD-1- and VEGF-blocking drug.

Via Investor's Business Daily

Amphenol Posts Better-Than-Expected Results, Joins SAP, Tesla, Pegasystems And Other Big Stocks Moving Higher On Wednesday ↗

April 23, 2025

Via Benzinga

BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025

April 22, 2025

From BioNTech SE

Via GlobeNewswire

10 Health Care Stocks Whale Activity In Today's Session ↗

April 18, 2025

Via Benzinga

Novavax Covid Vaccine Shows Milder Side Effects Than Pfizer-BioNTech's Shot: Study ↗

April 15, 2025

Novavax updated Covid vaccine showed fewer and milder side effects than Pfizer-BioNTech's in a Utah study.

Via Benzinga

Novavax Retail Traders Rally In Defense After RFK Jr.'s COVID-19 Vaccine Skepticism Sends Stock Tumbling ↗

April 10, 2025

Kennedy singled out the Novavax COVID-19 shot's single-antigen composition as the reason behind the delay in granting full approval.

Via Stocktwits

Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks. ↗

April 10, 2025

From vaccines to fluoride and beef tallow, here's where Robert F. Kennedy Jr. is making changes to health care.

Via Investor's Business Daily

Topics Government

BioNTech Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) ↗

April 01, 2025

Via Benzinga

European Patent Office Rules Vaccine Developer CureVac's Amended Patent Valid, Stock Jumps ↗

March 28, 2025

CureVac's amended patent survives BioNTech's challenge as EPO upholds validity. A German court will decide on infringement in July 2025.

Via Benzinga

Topics Intellectual Property

BioNTech's 2025 Revenue View, Vaccine Policy Uncertainty Prompt Price-Target Cut: Retail Stays Cautiously Optimistic ↗

March 10, 2025

For the current year, BioNTech projected revenue of 1.7 billion euros to 2.2 billion euros, below the market consensus of 2.54 billion euros and a fall from last year's 2.75 billion euros.

Via Stocktwits

BioNTech Se (BNTX) Q4 2024 Earnings Call Transcript ↗

March 10, 2025

BNTX earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday? ↗

March 10, 2025

Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:TSLA) and Palantir...

Via Benzinga

Topics Economy Stocks

Pfizer's COVID-19 Shot Partner BioNTech Reports Q4 Profit, But 2025 Guidance Falls Short On Expectations ↗

March 10, 2025

BioNTech's Q4 revenue beat estimates despite lower COVID-19 vaccine sales. The company advances oncology programs, with key data updates expected in 2025.

Via Benzinga

BioNTech Surpasses Q4 Revenue Estimates ↗

March 10, 2025

BioNTech SE exceeded earnings expectations with strong oncology pipeline development, despite reduced vaccine revenue.

Via The Motley Fool

US Stocks Likely To Open Lower After Trump Hints At Looming Recession: Expert Says Can't Rule Out A Bear Market As Indices Inch Towards Correction Territory ↗

March 10, 2025

U.S. stock futures declined on Monday after a small bout of relief on Friday as indices neared the correction zone.

Via Benzinga

Topics Government

BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update

March 10, 2025

From BioNTech SE

Via GlobeNewswire

Earnings Scheduled For March 10, 2025 ↗

March 10, 2025

Via Benzinga

Dow Gains Over 200 Points But Records Weekly Loss: Fear Among Investors Eases But Greed Index Remains In 'Extreme Fear' Zone ↗

March 10, 2025

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

71 72 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.